packageCabozantinib
cabozantinib
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Cabozantinib is a protein kinase inhibitor used to treat cancers such as renal cell carcinoma and medullary thyroid cancer. It is authorised in the European Union for thyroid, kidney, and liver cancers and is used in cancer care.
Summary written by glm-5.3-flash from Wikidata Q795057 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | cabozantinib |
| ATC codes: | L01EX07, L01XE |
| DrugBank: | DB08875 |
| PubChem CID: | 25102847 |
| ChEBI: | 72317 |
| Wikidata: | Q795057 |
| formula: | C28H24FN3O5 |
| molar mass: | 501.514 g/mol (PubChem CID 25102847) |
| logP: | 5.4 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |